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Abstract 
Effective management of oxygenation of preterm infants in critical care profoundly impacts their outcome. Nurses are 
challenged to titrate the inspired oxygen in response to constant cardiopulmonary instability. Closed loop control of 
inspired oxygen based on continuous monitoring of oxygen saturation is just becoming available. Evaluating the 
relative effectiveness of closed loop control systems is complicated by the wide variability in manual control by nurses. 
This analysis explored the possibility of a lag in effective control associated with the transition from closed loop to 
manual control using data from a clinical crossover trial. A short but marked lag phase was detected. It is, however, 
unlikely to have impact on clinical care or crossover studies. Its presence highlights the anticipative nature of closed 
loop control as contrasted to the observative nature of manual control.  
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Introduction 
 
After decades of promising research the closed loop 
control of inspired oxygen (FiO2) based on pulse 
oximetry (SpO2) is finally becoming available in the 
neonatal ICU. [1, 2, 3] Its routine clinical adoption will 
dramatically reduce the challenging and frustrating task 
nurses face in adjusting inspired oxygen in preterm 
infants during their weeks of respiratory support. [1, 2, 
3] Numerous studies of preterm infants have shown the 
criticality of maintaining oxygen saturation in a “sweet 
spot” to balance the risk of bad outcomes associated 
with both hyperoxemia and hypoxemia. [4] Therefore 
better control of SpO2, that has become associated with 
closed loop control, further offers the promise of 
improved outcomes. [1, 3] 
The uptake of oxygen from the alveoli to the 
pulmonary capillaries is quite fast. Further the time 
constant of washing in inspired gases throughout the 
lung is certainly less than a minute. [5] In the neonatal 
ICU numerous factors have impact. The equipment 
dead space and time constants associated with changes 
in SpO2 in response to an adjustment of FiO2 in the 
ventilator were recently characterized during res-
piratory support in the neonatal ICU. [6] Of course the 
lag phase, from adjustment to first response, varies 
primarily according to the ventilator, breathing circuit 
dead space and other ventilator system considerations. 
Further, as would be expected, there is also variation in 
the time constant and gain associated with a change in 
inspired and arterial oxygen, based on the respiratory 
mechanics and pathophysiology of the infant. Most 
automated FiO2-SpO2 control systems measure SpO2 
and adjust FiO2 much faster than the infant-ventilation 
response. [3] The opposite is true during manual 
control. However, one small study of manual and 
automated control suggested that quicker response, 
whether associated with auto or dedicated manual 
control, resulted in more effective control. [7] 
Nevertheless quicker increases must also be associated 
with quicker decreases when faced with hyperoxemia.  
Some automated systems have also been charac-
terized as having an anticipative component in their 
control algorithms. [3] As an example, they might 
consider the rate of change of the SpO2 in making 
a decision about the next FiO2 adjustment. In contrast, 
routine manual control would be characterized as 
observative. That is, the nurse waits to observe the 
complete response to a change in FiO2 before 
considering the need for another change.  
Physiological crossover studies should always 
consider the kinetics of the therapeutic intervention, 
and employ an adequate washout period between 
interventions. Nearly all of the evaluations of 
automated FiO2-SpO2 control utilized a physiological 
crossover design. However, because the SpO2 response 
to changes in inspired oxygen was known to be quite 
rapid compared to the duration of the intervention 
periods, washout periods in these studies have been 
considered unnecessary.  
The aim of this study was to determine if there was a 
clinically relevant crossover effect when switching 
from automated to manual FiO2-SpO2 control. We 
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speculated that the transition from automated to manual 
control, by virtue of its observative character, would 
result in a distinct transition. 
 
 
Methods 
 
Source data from a large crossover trial was used. [8] 
This trial enrolled 80 preterm infants at 9 centers. The 
order of intervention was randomized, with 40 rece-
iving manual control after automated control. The 
database included the subjects’ demographics as well 
as SpO2 data sampled every 5 seconds for the two 24-
hour intervention periods. Five of the 40 cases that 
transitioned from automated control to manual control 
were randomly selected. In addition, for the purpose of 
subjective comparison, 5 of the other 40 cases that 
transitioned from manual to automated control were 
also randomly selected. SpO2 data were extracted for 
the hour before and after the transitions between 
automated and manual control. 
The system used in the van Kaam trial [8] was the 
AVEA-CLiO2 (CareFusion, Yorba Linda CA, USA). 
This system had been commercially available in 
Europe for a number of years. The control algorithm 
continuously monitors FiO2 and SpO2 and makes a 
decision every second about whether a change in FiO2 
is needed. The decision is based on a set of rules that 
vary depending on whether the SpO2 is below, within 
or above the set SpO2 control range. The rules, while 
varying depending on that range, all consider 
6 parameters. These are the rate of change of SpO2, the 
direction of change, the time outside the target range, 
the absolute deviation from the target range, the 
reliability of the pulse oximetry signal and the baseline 
FiO2. More details of the control algorithm and system 
performance are available. [3, 8] 
Mean SpO2 was prospectively defined as the primary 
metric of control. The proportion of times with possible 
hypoxemia and possible hyperoxemia were selected as 
secondary endpoints, that might be associated with 
a shift in the mean. Possible hypoxemia and 
hyperoxemia were define as SpO2<86% and 
SpO2>96% when not inspiring room air, respectively. 
The presence of a relevant transition/washout was 
subjective, determined graphically. A 2-minute rolling 
mean of the SpO2 was used to filter out the normal 
rapid variation in SpO2 to facilitate identification of 
a transition effect. A two-minute averaging was selec-
ted as nearly all desaturation episodes are less than 
1 minute. [9] 
Differences in the mean SpO2 were evaluated using 
a pooled two-sample t test. Differences in hyperoxemia 
and hypoxemia were evaluated using a Z-test of 
proportions. A P value of <0.05 was considered 
statistically significant. Statistical analyses were 
conducted using XLStat (v16.6.03, Addinsoft USA).  
 
Results 
 
The 10 subjects selected were preterm infants studied 
in 4 neonatal ICUs. The interquartile range of their 
demographics were as follows: estimated gestational 
age (25?26 weeks), age and weight when studied 
(16.5?27.8 days) and (0.97?1.22 kg). Most were 
receiving noninvasive respiratory support (6 continu-
ous positive airway pressure, 2 intermittent positive 
pressure). During this two-hour analysis period the 
interquartile range of the SpO2 was 91?96% in the 
automated to manual group and 90?95% in the manual 
to automated group.  
Figures 1ab present the rolling average of the SpO2 
over the two-hour analysis periods. As would be 
expected even with the rolling average the SpO2 is not 
stable. The transition to manual from automated 
control is clear with a marked drop in SpO2 (Figure 
1a). A transition period of 10 minutes was selected 
after creating the charts. The slope of the rolling 
average at the boundaries to the 10-minute transition 
period suggests a precipitous transition. In contrast 
(Figure 1b) no transition period is apparent when 
switching to automated from manual control.  
 
 
a. Automated control followed by manual control. 
 
 
b. Manual control followed by automated control. 
 
Fig. 1ab: Two-hour period, rolling average of SpO2 
across the transition.  
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The actual means for all the 5-second data points in 
two 10-minute transition periods are compared to the 
subsequent 50 minutes and shown in Table 1. As 
suggested in Figure 1a, during manual control the mean 
SpO2 in the transition is significantly lower (2.4% 
SpO2, P<0.001). In contrast, consistent with Figure 1b, 
there was no apparent difference in mean SpO2 
transitioning to automated control. The variation of 
SpO2 (standard deviation) was similar among the 
periods.  
 
Tab. 1: Comparison of SpO2 during the two periods 
(transition and balance) during manual and automated 
FiO2 control. 
 
 
10 
minutes 
50 
minutes 
P 
Automated 91.8 (5.2) 92.0 (5.0) ns 
Manual 90.9 (4.7) 93.3 (5.3) <0.001 
Mean (std), P from two sample t-test. 
 
The lower mean SpO2 during the manual transition 
also impacted the distribution at SpO2 extremes. The 
percent time with a SpO2 reflective of a risk of 
hypoxemia was higher during the transition (16.9% vs 
7.2%, P<0.001) and correspondingly less with a risk of 
hyperoxemia (15.7% vs 25.9%, P<0.001). The percent 
time with SpO2 between these two extremes, 
normoxemia, was however unchanged (67.4% vs 
66.9%, P=ns). 
 
 
Discussion 
 
The maintenance of SpO2 at the beginning of manual 
control of FiO2 was different than during ongoing 
control, as hypothesized. A similar transition was not 
seen when starting automated control. In the clinical 
environment drops in SpO2 are usually a result of 
disordered breathing. Thus maintaining desired SpO2 
levels necessitates intermittent increases in FiO2. 
During the manual control transition period the SpO2 
was lower, consistent with the observational nature of 
manual control.  
We found the transition period was about 10 
minutes. Fathabadi et al, reported on the neonatal SpO2 
response to changes based on 580 isolated increases in 
FiO2 in 47 subjects. [6] They reported a typical delay 
of 22 seconds (IQR 8?40) before SpO2 started to 
increase. They also found that the 95% response to an 
increase in FiO2 was 39 seconds (IQR 7?105). While 
they reported considerable variation among episodes 
and subjects, this data suggests that two or three adjust-
ments, each occurring after observing the response to 
the last adjustment, nominally a minute, would be 
much shorter than the 10 minutes that was identified as 
the transition period. We speculate therefore that 
during manual control the periods of observation from 
initiation and subsequent FiO2 adjustments are much 
longer than the physiological responses. This is consis-
tent with the multitasking required of neonatal nurses.   
While the SpO2 transition to manual adjustment was 
marked, the rolling average SpO2 stayed within the 
range associated with normoxemia (SpO2 86?96%). 
The shift to lower levels resulted, nevertheless, in 
significant differences in SpO2 exposure. Specifically, 
there was an increased exposure to potential 
hypoxemia and decreased exposure to potential 
hyperoxemia. Differences of this magnitude are 
certainly clinically relevant, if they were to persist for 
a significant amount of time. [9, 10] It is unlikely, 
however, that infrequent transitions associated with 
shift or staffing changes would occur frequently 
enough to impact accumulative exposure. However 
some part of the differences reported with staffing 
levels might be associated with transitions associated 
with attending to particularly unstable infants. [11]  
It appears that the transition period would not have 
a material effect on the results of crossover studies of 
FiO2-SpO2 control systems. As an example, even in 
a study with 4-hour intervention periods a 10-minute 
transition would represent only 4.2% of the inter-
vention time. Studies more typically have utilized 12 or 
24-hour intervention periods.  
This study has some limitations. The analysis is 
based on the response of 5 subjects. While they were 
picked at random from a larger population, selection of 
different subjects might have resulted in different 
results. The analysis also used the pooled response of 
the subjects, a larger study evaluating paired within-
subject differences would provide information about 
the variation among subjects. Nevertheless the 
differences we found were clinically relevant and 
highly statistically significant. This data came from 
a controlled trial in which the caregivers knew their 
manual control was being studied. In such circum-
stances one would expect the control would better, and 
thus the effect less pronounced than during routine 
care. The actual transition effect associated with shift 
changes should be studied at centers with appropriate 
patient data monitoring systems.  
 
 
Conclusion 
 
There appears to be a lag phase with a drop in SpO2 
at the beginning of manual titration of FiO2. This 
transition phase is longer than just the physiological 
response would predict. Its duration and magnitude are 
not sufficient to have any impact on patient risk or 
study design.  
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